ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 117

$1.05M Total Retail Price of All Prescriptions

Rank: 21 out of 117

272 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 272 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

28% of this provider’s 272 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 15,175 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

64 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 659 617 1 4
LEVOTHYROXINE SODIUM 637 585 2 1
LISINOPRIL 625 571 3 6
SIMVASTATIN 531 452 4 2
WARFARIN SODIUM 448 392 5 13
METOPROLOL TARTRATE 427 337 6 8
DONEPEZIL HCL 409 391 7 10
AMLODIPINE BESYLATE 402 352 8 5
HYDROCODONE-ACETAMINOPHEN 382 317 S3 9 3
NAMENDA 354 333 10 7
MIRTAZAPINE 312 292 11 14
OMEPRAZOLE 274 229 12 9
RISPERIDONE 273 252 13 35
TRAZODONE HCL 249 210 14 23
POTASSIUM CHLORIDE 235 218 15 11
METFORMIN HCL 230 212 16 15
KLOR-CON M10 210 201 17 76
SERTRALINE HCL 204 156 18 16
QUETIAPINE FUMARATE 198 178 19 20
LEVOFLOXACIN 197 171 20 55
ESCITALOPRAM OXALATE 195 159 21 29
GABAPENTIN 191 174 22 12
CITALOPRAM HBR 191 187 22 18
NOVOLIN R 186 172 24 40
ATORVASTATIN CALCIUM 185 170 25 21
PANTOPRAZOLE SODIUM 183 132 26 39
KLOR-CON M20 182 157 27 54
DIVALPROEX SODIUM 180 115 28 37
CARVEDILOL 177 148 29 22
TAMSULOSIN HCL 171 154 30 31
EXELON 161 161 31 34
ALENDRONATE SODIUM 153 115 32 26
LANTUS 148 114 33 25
CYMBALTA 147 114 34 27
TRAMADOL HCL 140 130 35 19
IPRATROPIUM-ALBUTEROL 139 120 36 59
CLOPIDOGREL 134 106 37 30
OXYBUTYNIN CHLORIDE ER 133 129 38 85
GLIPIZIDE 132 130 39 51
POLYETHYLENE GLYCOL 3350 126 93 40 61
ZOLPIDEM TARTRATE 125 93 41 24
BACLOFEN 121 64 42 74
DIGOXIN 109 98 43 45
LEVETIRACETAM 104 65 44 46
LIDODERM 103 88 45 62
CLONIDINE HCL 98 80 46 52
METOPROLOL SUCCINATE 97 97 47 17
CARBIDOPA-LEVODOPA 96 93 48 53
PLAVIX 93 70 49 41
DIOVAN 90 90 50 38
NOVOLOG 89 78 51 60
GENERLAC 89 70 51 141
GLIPIZIDE ER 86 62 53 143
HYDRALAZINE HCL 85 62 54 50
FINASTERIDE 85 85 54 111
AMIODARONE HCL 84 75 56 98
SEROQUEL 80 71 57 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 68 58 79
LACTULOSE 78 74 59 65
ENULOSE 75 51 60 231
ISOSORBIDE MONONITRATE ER 75 45 60 48
ATENOLOL 74 74 62 42
SPIRIVA 71 71 63 80
JANTOVEN 70 66 64 120
LOVASTATIN 70 59 64 92
LEXAPRO 67 59 66 86
CIPROFLOXACIN HCL 67 56 66 56
FLUTICASONE PROPIONATE 65 64 68 44
BENZTROPINE MESYLATE 65 65 R 68 97
PRAVASTATIN SODIUM 64 64 70 33
PAROXETINE HCL 64 54 70 82
PREDNISONE 64 62 70 47
HYDROCHLOROTHIAZIDE 63 50 73 28
SANTYL 61 58 74 100
LIDOCAINE HCL 61 54 74 125
DOXAZOSIN MESYLATE 60 60 76 124
ABILIFY 60 60 76 75
CEFTRIAXONE 59 49 78 129
ADVAIR DISKUS 59 54 78 71
AMOX TR-POTASSIUM CLAVULANATE 59 50 78 102
TRANSDERM-SCOP 56 37 81 217
ZETIA 52 20 82 130
NYSTATIN 51 48 83 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.